Robin Vacha's most recent trade in Azenta Inc was a trade of 324 Common done at an average price of $39.4 . Disclosure was reported to the exchange on Feb. 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Azenta Inc | Robin Vacha | SVP, GM Life Science Products | Grant, award, or other acquisition of securities at price $ 39.41 per share. | 01 Feb 2024 | 324 | 31,287 (0%) | 0% | 39.4 | 12,769 | Common |
| Azenta Inc | Robin Vacha | SVP, GM Life Science Products | Grant, award, or other acquisition of securities at price $ 53.01 per share. | 31 Jan 2024 | 151 | 31,438 (0%) | 0% | 53.0 | 8,005 | Common |
| Azenta Inc | Vacha Robin | SVP, GM Life Science Products | Sale or transfer of securities back to the company at price $ 56.60 per share. | 05 Dec 2023 | 5,175 | 25,788 (0%) | 0% | 56.6 | 292,905 | Common |
| Azenta Inc | Robin Vacha | SVP, GM Life Science Products | Grant, award, or other acquisition of securities at price $ 55.00 per share. | 10 Aug 2023 | 7,400 | 25,220 (0%) | 0% | 55 | 407,000 | Common Stock |
| Azenta Inc | Robin Vacha | SVP, GM Life Science Products | Grant, award, or other acquisition of securities at price $ 39.98 per share. | 31 Jul 2023 | 121 | 32,620 (0%) | 0% | 40.0 | 4,838 | Common Stock |
| Azenta Inc | Robin Vacha | SVP, GM Life Science Products | Grant, award, or other acquisition of securities at price $ 46.92 per share. | 31 Jan 2023 | 265 | 32,499 (0%) | 0% | 46.9 | 12,434 | Common Stock |
| Azenta Inc | Robin Vacha | SVP, GM Life Science Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 3,778 | 32,234 (0%) | 0% | 0 | Common Stock | |
| Azenta Inc | Robin Vacha | SVP, GM Life Science Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 11,077 | 34,294 (0%) | 0% | 0 | Common Stock | |
| Azenta Inc | Robin Vacha | SVP, GM Life Science Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Nov 2022 | 5,838 | 28,456 (0%) | 0% | 0 | Common Stock | |
| Azenta Inc | Robin Vacha | SVP, GM Life Science Products | Grant, award, or other acquisition of securities at price $ 69.29 per share. | 31 Jan 2022 | 285 | 23,217 (0%) | 0% | 69.3 | 19,748 | Common Stock |
| Azenta Inc | Robin Vacha | SVP, GM BLS-Products | Sale of securities on an exchange or to another person at price $ 119.27 per share. | 17 Nov 2021 | 7,329 | 30,971 (0%) | 0% | 119.3 | 874,130 | Common Stock |
| Azenta Inc | Robin Vacha | SVP, GM BLS-Products | Sale of securities on an exchange or to another person at price $ 119.03 per share. | 17 Nov 2021 | 6,490 | 22,932 (0%) | 0% | 119.0 | 772,505 | Common Stock |
| Azenta Inc | Robin Vacha | SVP, GM BLS-Products | Sale of securities on an exchange or to another person at price $ 119.27 per share. | 17 Nov 2021 | 1,549 | 29,422 (0%) | 0% | 119.3 | 184,749 | Common Stock |
| Azenta Inc | Robin Vacha | SVP, GM BLS-Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 17,354 | 35,929 (0%) | 0% | 0 | Common Stock | |
| Azenta Inc | Robin Vacha | SVP, GM BLS-Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 1,748 | 37,677 (0%) | 0% | 0 | Common Stock | |
| Azenta Inc | Robin Vacha | SVP, GM BLS-Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 402 | 38,079 (0%) | 0% | 0 | Common Stock | |
| Azenta Inc | Robin Vacha | SVP, GM BLS-Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 221 | 38,300 (0%) | 0% | 0 | Common | |
| Azenta Inc | Robin Vacha | SVP, GM BLS-Products | Sale of securities on an exchange or to another person at price $ 69.62 per share. | 18 Nov 2020 | 4,757 | 20,308 (0%) | 0% | 69.6 | 331,182 | Common Stock |
| Azenta Inc | Robin Vacha | SVP, GM BLS-Products | Sale of securities on an exchange or to another person at price $ 69.62 per share. | 18 Nov 2020 | 1,733 | 18,575 (0%) | 0% | 69.6 | 120,651 | Common Stock |
| Azenta Inc | Robin Vacha | SVP, GM BLS-Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2020 | 11,947 | 22,328 (0%) | 0% | 0 | Common Stock | |
| Azenta Inc | Robin Vacha | SVP, GM BLS-Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2020 | 2,737 | 25,065 (0%) | 0% | 0 | Common Stock |